The tweet was deleted by the author.
But we saved everything 🙂.
Concerns over the influence of insurance companies and pharmacy benefit managers (PBMs) on the U.S. pharmaceutical supply chain are growing. Mark Cuban, a prominent entrepreneur, commented on social media about how the same firms accused of denying patient claims are also benefiting from strategic relationships related to formulary access. Cuban challenged industry members to address market dynamics where PBMs and insurers wield significant power, particularly regarding pricing and distribution practices. The ongoing debate in the U.S. healthcare sector centers on transparency and accountability, with tensions mounting between manufacturers, distributors, and intermediaries.
Cuban has previously commented on structural challenges in U.S. health care. He described large hospitals as a key obstacle in a recent statement on major hospital systems. Cuban has also made public comparisons of technology platforms, contrasting feedback from Claude AI with that from Johnny Roastbeef in a separate online discussion.